Pharmafile Logo

Curo

We are a global Pharma Market Access consultancy, with the core belief in adopting a collaborative approach to Payer engagement. Enabling you to speak to your Payer’s “in their language”.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….

View Profile

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Inizio

Welcome to Inizio. Your market-leading commercialization partner, providing tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Origins – The Patient Focused Specialists

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…

View Profile

Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.

View Profile

Red Thread Market Access Ltd

Blending brilliant writing with in-depth market access and reimbursement expertise

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

Chilterns House, Dean Street, Marlow, SL7 3AA, UK
+44 (0) 1628 486 048

 Latest Content from PMHub 

OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward

The COVID-19 pandemic has permanently changed how medical education in the healthcare industry is conducted. Over the last few months, all conferences, medical education and field force deliverables have either...

How Far Do You Want To Go?

Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…

“Fishbowl” Web Meeting for Internal POA Discussions: a Customer Story

Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting.

Embracing the QR code: a health and humanity perspective

Press Releases | October 16, 2020 | 11 London

Lately, you’ll be noticing them everywhere – the humble QR code is making a comeback. Once widely adopted in 2011, the codes’ usage had pretty much gone out of fashion...

Harnessing Technology to Improve Health and Healthcare

Steven Collens, Chief Executive Officer at MATTER, discusses his professional journey, his work to empower digital health technology startups, and how MATTER is helping businesses define their challenges, identify solutions, and innovate...

Telemedicine and the Digitization of Medicine post COVID-19

Samantha Lippolis, Telehealth Advisor at Sam I am Innovates; Dr. Daniel Fagbuyi, CEO of Erudition; Dr. Brian Block, Health Care Consultant at Brian Block Consulting; Mindy Klowden, Director of Strategic Initiatives at the Colorado Behavioral Healthcare...

Innovative Medical Solutions for Postponing and Undoing Age-related Disease

Aubrey de Grey, Chief Science Officer at SENS Research Foundation, explores the concept of using biomedical technology and regenerative medicine to postpone aging-derived debilitation and death. We dive into many questions surrounding...

Looking after the mental wellbeing of the Porterhouse family

At Porterhouse Medical Group, as a busy insight-led healthcare communications agency group, we recognise the importance of mental health and that mental health issues are a normal part of life...

OLED Medical Technology Saving Patient’s Sight During COVID-19 Pandemic

Press Releases | October 14, 2020 | Onyx Health

North East MedTech company secures investment agreement with Japanese tech giant

NORD Rare Diseases Breakthrough Summit

Gavin Jones, Director of Rare Disease, provides his thoughts on last week’s NORD Breakthrough Summit and a collective need to reduce inequalities in rare disease